Account
Sign In
Home
Daily Diary
Asset Class
Fixed Income
Currencies
US Equity
Specialty
Global Equity & Income
Commodities
Sectors
Healthcare
Financial Services
Basic Materials
Consumer Cyclicals
Telecom Services
Energy
Transportation
Consumer Staples
Industrials
Utilities
Technology
Real Estate
Latest
Columnist Conversation
Video
Street Notes
Authors
Bruce Kamich
Jim Cramer
Jim "Rev Shark" DePorre
Brian Sozzi
Helene Meisler
Jonathan Heller
Roger Arnold
- See All -
Options
RMPIA
Switch Product
Action Alerts PLUS
Daily Swing Trade Archive
Income Seeker
Quant Ratings
Retirement
Stocks Under $10
TheStreet
Top Stocks
Trifecta Stocks
Information Provided By:
Visit TheFly.com
TheFly.com Free Trial
Fly News Breaks for February 9, 2020
ADVM
Get Breaking Institutional Stock News For
Free
with a 14 day trial
18:23 EST Adverum Biotechnologies upgraded to Overweight from Neutral at Cantor Fitzgerald
Feb 9, 2020 | 18:23 EDT
Cantor Fitzgerald analyst Alethia Young upgraded Adverum Biotechnologies to Overweight from Neutral with a price target of $21, up from $8.
News For ADVM From the Last 2 Days
ADVM
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Adverum Biotechnologies management to meet with Truist
Apr 26, 2024 | 07:34 EDT